Fcγ-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments
about
Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy.Clinically significant anti-KEL RBC alloantibodies are transferred by breast milk in a murine model.Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeysReactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells.A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies.Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production.Ofatumumab for the treatment of chronic lymphocytic leukemia.Treatment of chronic lymphocytic leukemia with monoclonal antibodies, where are we heading?Lupus nephritis and B-cell targeting therapy.Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor CellsAnti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages.Maxed out macs: physiologic cell clearance as a function of macrophage phagocytic capacity.Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice.In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy.Antibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo.Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model.Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab.Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity.Neutrophils kill the parasite Trichomonas vaginalis using trogocytosis.Role for ZAP-70 Signaling in the Differential Effector Functions of Rituximab and Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia B Cells.HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma.
P2860
Q36437030-81FB4BF6-52C7-469A-9B2D-5327684EF346Q37079801-7CB382F2-0762-4961-B764-7344344CBC99Q37141605-54DE78BB-81A8-4F46-B041-AB136F059DE8Q37362596-862A5513-94E3-4792-B98B-B0069F913C27Q37672472-F2D333B0-7AAE-4096-B41B-13849BC6B16BQ37741570-1D4D78B7-5CFA-4B95-A426-A389B97732EEQ38424862-244796B2-0902-4D04-B5E8-9985DF7A5247Q38573785-7250D456-683F-4225-B362-7D5FF62895C1Q38643755-23751D40-31B7-4119-B544-9C766E2FC12CQ38768387-1FF0DDAF-404D-4479-B773-5F3421705357Q38970811-C46BB747-1648-43D5-A029-C05C30C52B32Q39013196-B79A4054-F9FB-4A47-AD0A-B856384526B2Q39335573-AEEE3C08-108A-4413-A009-229C90D94D5CQ40218347-A1672718-6BD0-4F0B-B7B6-A496CBCD8B37Q41620299-9EEA6C01-D099-416F-BD9F-D008CEED1625Q42372842-D8EB808D-437C-458A-A0DC-5B1E29DDEDEDQ43234219-75D22F87-CD5D-4C14-9C8B-3C6923B81034Q47660573-8CDD515F-8C51-43CB-A3A2-512DAC928888Q48223734-DE957CEA-A7B1-47F7-A68E-DDC39FFE6A10Q50162422-F9C384C7-1761-4D7E-ABF1-A014BC548435Q50889845-71C8421B-D8B4-494A-9275-F8D1D07308CAQ52598776-BFFE8311-9D17-4565-B71D-53395022C371Q55094448-E0ABE175-6B88-4B64-A096-3B2D33A898A4
P2860
Fcγ-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Fcγ-receptor-mediated trogocyt ...... edence and recent developments
@ast
Fcγ-receptor-mediated trogocyt ...... edence and recent developments
@en
Fcγ-receptor-mediated trogocyt ...... edence and recent developments
@nl
type
label
Fcγ-receptor-mediated trogocyt ...... edence and recent developments
@ast
Fcγ-receptor-mediated trogocyt ...... edence and recent developments
@en
Fcγ-receptor-mediated trogocyt ...... edence and recent developments
@nl
prefLabel
Fcγ-receptor-mediated trogocyt ...... edence and recent developments
@ast
Fcγ-receptor-mediated trogocyt ...... edence and recent developments
@en
Fcγ-receptor-mediated trogocyt ...... edence and recent developments
@nl
P3181
P1433
P1476
Fcγ-receptor-mediated trogocyt ...... edence and recent developments
@en
P2093
M. A. Lindorfer
R. P. Taylor
P3181
P356
10.1182/BLOOD-2014-10-569244
P407
P577
2015-01-29T00:00:00Z